Skip to content

Comparison between local application of eyedrop Chloroquine Phosphate and eyedrop Cyclosporine-A in Post LASIK dry eye

Comparative Evaluation of Topical Chloroquine Phosphate and Topical Cyclosporine-A in Post LASIK Ocular Surface Stability

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015175
Enrollment
120
Registered
2018-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- post LASIK surgery tear film and ocular surface stability

Interventions

Intervention1: E/D chloroquine phosphate 0.03% along with standard treatment: E/D chloroquine phosphate 0.03% BD for 3months along with standard treatment (E/D Moxifloxacin 0.5% Tds, E/D Predacetate Q

Sponsors

Dr Jeewan S Titiyal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients must be 18 years of age or older 2.Stable refractive error for at least 1 year 3.Myopia >=1D and & 4.Astigmatism 5.Minimum calculated residual corneal stromal bed thickness of at least 300µm 6.Patients giving informed consent for trial 7.Patients willing for follow up

Exclusion criteria

Exclusion criteria: 1.Hyperopic patients 2.Patients with pre-operative severe dry eye 3.Patients diagnosed with external ocular disease or history of previous ocular surgery 4.Subjects with permanent or temporary lacrimal punctual occlusion 5.Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites 6.Patients suffering from systemic diseases likely to affect wound healing, such as diabetes,connective tissue disease, and severe atopy; pregnancy or nursing 7.Keratoconus/forme-fruste keratoconus/ Pellucid Marginal Degeneration patients 8.Progressive or unstable myopia and/or astigmatism 9.Previous corneal surgery/Re-surgery

Design outcomes

Primary

MeasureTime frame
OSDI score Tear Osmolarity level Tear MMP-9 levelTimepoint: preop, day1, 1week, 1month, 3month, 6month

Secondary

MeasureTime frame
Tear Break Up Time (TBUT) Schirmer Test NEI Score Fluoroscein stain scoreTimepoint: preop, day1, 1week, 1month, 3month, 6month

Countries

India

Contacts

Public ContactDR ANANYA GOSWAMI

All India Institute of Medical Sciences, New Delhi

titiyal@gmail.com9810649942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026